Who
Douglas Beck
PAO SVP of Finance Controller
Company insider
Files Form 4 as: PAO SVP of Finance Controller, SHF Holdings; Chief Financial Officer, Beyond Air; Chief Financial Officer, Relmada Therapeutics; Chief Financial Officer, Lev Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 9
- Sells
- 0
- Bought
- $124K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 0
- First trade
- 7 Jun 2006
- Last trade
- 30 Sep 2025
- Last filed
- 8 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2025filed 8 May 2026 | SHFS SHF Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —45,875 at $0.00 | filing |
| 30 Sep 2025filed 8 May 2026 | SHFS SHF Holdingsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —45,875 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $5,3801,000 at $5.38 | filing |
| 4 Mar 2021filed 8 Mar 2021 | XAIR Beyond Airoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 31 Dec 2020filed 31 Dec 2020 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $16K3,000 at $5.28 | filing |
| 24 Sep 2020filed 31 Dec 2020 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $15K3,000 at $4.88 | filing |
| 24 Sep 2020filed 25 Sep 2020 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $15K3,000 at $4.88 | filing |
| 13 Nov 2019filed 18 Nov 2019 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $6,2451,569 at $3.98 | filing |
| 13 Nov 2019filed 13 Nov 2019 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $4,9931,242 at $4.02 | filing |
| 12 Nov 2019filed 13 Nov 2019 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $2,742689 at $3.98 | filing |
| 8 Nov 2019filed 13 Nov 2019 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $9,2032,250 at $4.09 | filing |
| 3 Jun 2019filed 13 Nov 2019 | XAIR Beyond AirMedical Devices | SEC FORM 4 Bought | $50K9,710 at $5.15 | filing |
| 2 Nov 2018filed 6 Nov 2018 | XAIR Beyond Airoption or derivative · Medical Devices | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 23 Feb 2015filed 5 Mar 2015 | RLMD Relmada Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $68K25,000 at $2.70 | filing |
| 21 Oct 2008filed 21 Oct 2008 | Lev Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —100,000 | filing |
| 21 Oct 2008filed 21 Oct 2008 | Lev Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —125,000 | filing |
| 7 Jun 2006filed 9 Jun 2006 | Lev Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
News
Beyond air power: How long-range missiles are reshaping the rules of warXAIR · indiatimes.com · 19 Oct 2026
0 headlines in the last 90 days name Douglas Beck; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.